FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 95,702,027
- Share change
- +1,122,318
- Total reported value
- $5,670,584,893
- Put/Call ratio
- 268%
- Price per share
- $59.27
- Number of holders
- 254
- Value change
- +$32,917,992
- Number of buys
- 130
- Number of sells
- 121
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
11%
|
12,957,222
|
$1,124,557,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.2%
|
7,570,681
|
$657,060,000 | — | 30 Jun 2021 | |
| ARK Investment Management LLC |
13F
|
Company |
6.1%
|
7,483,102
|
$649,458,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
6,595,960
|
$572,464,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
5.3%
|
6,450,926
|
$559,876,000 | — | 30 Jun 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
2.8%
|
3,400,000
|
$295,086,000 | — | 30 Jun 2021 | |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
|
Company |
2.8%
|
3,379,064
|
$293,269,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.5%
|
3,109,832
|
$269,902,000 | — | 30 Jun 2021 | |
| Bellevue Group AG |
13F
|
Company |
2.1%
|
2,613,536
|
$226,829,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
2,054,546
|
$178,314,000 | — | 30 Jun 2021 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.6%
|
1,905,000
|
$165,335,000 | — | 30 Jun 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.5%
|
1,825,984
|
$158,477,000 | — | 30 Jun 2021 | |
| LONE PINE CAPITAL LLC |
13F
|
Company |
1.4%
|
1,749,284
|
$151,820,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
1,571,563
|
$136,396,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,418,406
|
$123,103,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
1.1%
|
1,350,000
|
$117,167,000 | — | 30 Jun 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
1,315,601
|
$114,181,000 | — | 30 Jun 2021 | |
| Grosvenor Holdings, L.L.C. |
13F
|
Company |
0.85%
|
1,041,507
|
$90,392,000 | — | 30 Jun 2021 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.84%
|
1,032,080
|
$89,574,000 | — | 30 Jun 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.82%
|
1,007,783
|
$87,466,000 | — | 30 Jun 2021 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
0.84%
|
1,025,519
|
$87,313,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.78%
|
949,772
|
$82,429,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
884,680
|
$76,781,000 | — | 30 Jun 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.72%
|
884,134
|
$76,734,000 | — | 30 Jun 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.69%
|
847,723
|
$73,574,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.65%
|
792,061
|
$68,742,000 | — | 30 Jun 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.61%
|
743,992
|
$64,571,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.6%
|
732,000
|
$63,530,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
0.59%
|
727,557
|
$63,145,000 | — | 30 Jun 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.57%
|
696,336
|
$60,435,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.56%
|
686,484
|
$59,580,000 | — | 30 Jun 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.55%
|
668,448
|
$58,016,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.49%
|
593,442
|
$51,504,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
583,138
|
$50,611,000 | — | 30 Jun 2021 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
0.47%
|
569,889
|
$49,461,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.38%
|
468,864
|
$40,694,000 | — | 30 Jun 2021 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.34%
|
417,358
|
$36,223,000 | — | 30 Jun 2021 | |
| Amundi |
13F
|
Individual |
0.33%
|
408,487
|
$35,453,000 | — | 30 Jun 2021 | |
| Eversept Partners, LP |
13F
|
Company |
0.28%
|
346,347
|
$30,059,456 | — | 30 Jun 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.28%
|
343,567
|
$29,818,181 | — | 30 Jun 2021 | |
| Darwin Global Management, Ltd. |
13F
|
Company |
0.27%
|
335,918
|
$29,154,000 | — | 30 Jun 2021 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.27%
|
335,427
|
$29,112,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
327,468
|
$28,421,000 | — | 30 Jun 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.27%
|
326,769
|
$28,360,000 | — | 30 Jun 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.26%
|
314,360
|
$27,283,000 | — | 30 Jun 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.25%
|
304,000
|
$26,384,000 | — | 30 Jun 2021 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.25%
|
301,651
|
$26,180,000 | — | 30 Jun 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
293,075
|
$25,436,000 | — | 30 Jun 2021 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
272,766
|
$23,673,000 | — | 30 Jun 2021 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.22%
|
270,000
|
$23,433,000 | — | 30 Jun 2021 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2021
As of 30 Sep 2021,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
254 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,702,027 shares.
The largest 10 holders included
Redmile Group, LLC, ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Casdin Capital, LLC, JOHNSON & JOHNSON, Bellevue Group AG, STATE STREET CORP, and FARALLON CAPITAL MANAGEMENT LLC.
This page lists
254
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
264
Q3 2021 holders
254
Holder diff
-10
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.